SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer.
about
A review of osteocyte function and the emerging importance of sclerostinGenome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.Down-regulation of SOSTDC1 promotes thyroid cancer cell proliferation via regulating cyclin A2 and cyclin E2SOSTDC1 is down-regulated in non-small cell lung cancer and contributes to cancer cell proliferation.Wnt/β-catenin Signaling in Normal and Cancer Stem Cells.Serum sclerostin levels in renal cell carcinoma patients with bone metastasesThe complex roles of Wnt antagonists in RCC.Transcriptome profiling of cancer and normal tissues from cervical squamous cancer patients by deep sequencingHepcidin regulation in prostate and its disruption in prostate cancer.Agonists and Antagonists of TGF-β Family Ligands.Roles of Grainyhead-like transcription factors in cancer.Bone morphogenetic proteins, breast cancer, and bone metastases: striking the right balance.Key Factors in Breast Cancer Dissemination and Establishment at the Bone: Past, Present and Future Perspectives.Identification of genes involved in cold-shock response in rainbow trout (Oncorhynchus mykiss).Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications.Identification of methylation sites and signature genes with prognostic value for luminal breast cancer.E4BP4 promotes thyroid cancer proliferation by modulating iron homeostasis through repression of hepcidin
P2860
Q34264395-469C33D5-198A-453F-87ED-4DCE11DC6A4BQ36093867-3BF12DE2-07AC-49C6-AD87-38BE589F14F4Q36544687-17ABD3BB-A25B-4C7A-ADB7-8EAE19E4C799Q36800327-61A788E6-55A3-4BE0-AEC8-B19E89EA44F7Q37132716-987D1182-DDE0-4470-8018-6EEB18D9C947Q37282121-E79BF35A-BD89-4287-A8F3-A6040B445E88Q37949269-22D41358-E2FE-4696-B7C0-87A0B871CFBDQ38431922-19AAEA44-7003-4168-AE63-B1DDDC7F38C5Q38889135-8C844483-E85A-48B9-B85C-82A50633857BQ38896053-1F19337A-1420-4D6B-8C0B-F54B4B58B90AQ39438840-667CC530-50F7-4C49-AECE-BB3E422E0182Q39451397-D4045851-B566-4B81-B6D1-0568BA5A56D3Q47250561-9F6993AE-4702-4BF0-8CB6-C97F262421CAQ47744008-946270E1-E906-4287-A504-9ABF67E80F31Q49389245-BFD1F9DE-57EF-4509-8D54-265CA07ADFBEQ52720003-12DB8E3B-89DE-4786-8A44-CE4AB1EDBF1CQ58700293-7005C182-D314-4ED3-89AE-6A9692EE7ECF
P2860
SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
SOSTDC1 differentially modulat ...... wn-regulated in breast cancer.
@en
type
label
SOSTDC1 differentially modulat ...... wn-regulated in breast cancer.
@en
prefLabel
SOSTDC1 differentially modulat ...... wn-regulated in breast cancer.
@en
P2093
P2860
P1476
SOSTDC1 differentially modulat ...... wn-regulated in breast cancer.
@en
P2093
Charles E Birse
Frank M Torti
Gregory B Russell
Kathryn A Clausen
Kimberly R Blish
Lance D Miller
Matthew A Triplette
Ralph B D'Agostino
Suzy V Torti
Timothy E Kute
P2860
P2888
P304
P356
10.1007/S10549-010-1261-9
P407
P577
2010-11-27T00:00:00Z